ALDRICH RICHARD
Insider CIK 1185039 · PTCT Director · KALV Director · CNCE Director, 10% owner · VSTM Director, 10% owner · OVAS Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 23,260 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 15,940 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 22,410 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 40,432 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | U Tender | 2023-03-06 | 2023-03-06 | 342,100 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer | 2023-03-06 | 2023-03-06 | 16,400 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | U Tender | 2023-03-06 | 2023-03-06 | 210,526 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | U Tender | 2023-03-06 | 2023-03-06 | 44,351 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2022-06-09 | 2022-06-13 | 22,410 | — | $0 | 22,410 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2022-06-09 | 2022-06-13 | 16,400 | — | $0 | 358,500 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2022-06-06 | 2022-06-06 | 210,526 | $4.75 | $1000.0K | 210,526 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2021-06-10 | 2021-06-11 | 10,250 | — | $0 | 10,250 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2021-06-10 | 2021-06-11 | 30,182 | — | $0 | 30,182 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2021-06-10 | 2021-06-11 | 5,125 | — | $0 | 342,100 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2020-06-11 | 2020-06-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2020-06-11 | 2020-06-12 | 13,260 | — | $0 | 13,260 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2019-06-13 | 2019-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award | 2018-12-07 | 2018-12-11 | 755 | — | $0 | 6,169 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2018-11-15 | 2018-11-15 | 40,000 | $11.78 | $471.2K | 336,975 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2018-11-15 | 2018-11-15 | 10,000 | $12.00 | $120.0K | 296,975 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2018-10-03 | 2018-10-05 | 7,000 | — | $0 | 7,000 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2018-09-28 | 2018-10-02 | 14,558 | — | $0 | 81,220 | SEC↗ |
| OVAS OvaScience, Inc. | A Award deriv | 2018-07-04 | 2018-07-06 | 12,000 | — | $0 | 12,000 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2018-06-29 | 2018-07-03 | 11,709 | — | $0 | 66,662 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2018-06-14 | 2018-06-18 | 5,940 | — | $0 | 15,940 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2018-06-14 | 2018-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2018-03-30 | 2018-04-03 | 13,101 | — | $0 | 54,953 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-02-01 | 2018-02-01 | 1,946 | $19.99 | $38.9K | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-31 | 2018-02-01 | 4,700 | $20.78 | $97.7K | 2,246 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-31 | 2018-02-01 | 300 | $21.29 | $6.4K | 1,946 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-30 | 2018-02-01 | 5,000 | $21.33 | $106.6K | 6,946 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-29 | 2018-01-29 | 5,000 | $21.36 | $106.8K | 11,946 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-26 | 2018-01-29 | 5,000 | $20.46 | $102.3K | 16,946 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-25 | 2018-01-29 | 5,000 | $20.31 | $101.5K | 21,946 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-25 | 2018-01-29 | 3,054 | $20.22 | $61.8K | 44,351 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-24 | 2018-01-24 | 5,000 | $19.83 | $99.1K | 26,946 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-24 | 2018-01-24 | 5,000 | $19.83 | $99.1K | 47,405 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-23 | 2018-01-24 | 5,000 | $19.67 | $98.4K | 31,946 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-23 | 2018-01-24 | 5,000 | $19.68 | $98.4K | 52,405 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-22 | 2018-01-24 | 5,000 | $19.55 | $97.8K | 36,946 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-22 | 2018-01-24 | 5,000 | $19.54 | $97.7K | 57,405 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-19 | 2018-01-19 | 5,000 | $19.65 | $98.3K | 62,405 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-19 | 2018-01-19 | 5,000 | $19.66 | $98.3K | 41,946 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-18 | 2018-01-19 | 5,000 | $19.43 | $97.2K | 67,405 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-18 | 2018-01-19 | 5,000 | $19.36 | $96.8K | 46,946 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-17 | 2018-01-19 | 5,000 | $18.95 | $94.8K | 51,946 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-17 | 2018-01-19 | 5,000 | $19.03 | $95.2K | 72,405 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2018-01-16 | 2018-01-18 | 5,309 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2018-01-16 | 2018-01-18 | 5,309 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2018-01-16 | 2018-01-18 | 5,309 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2018-01-16 | 2018-01-18 | 5,309 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2018-01-16 | 2018-01-18 | 5,309 | $3.79 | $20.1K | 297,593 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2018-01-16 | 2018-01-18 | 5,309 | $2.88 | $15.3K | 308,211 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-16 | 2018-01-18 | 21,236 | $19.08 | $405.2K | 286,975 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-16 | 2018-01-18 | 5,000 | $19.27 | $96.3K | 56,946 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-01-16 | 2018-01-18 | 5,000 | $19.26 | $96.3K | 77,405 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2018-01-16 | 2018-01-18 | 5,309 | $4.41 | $23.4K | 292,284 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2018-01-16 | 2018-01-18 | 5,309 | $3.50 | $18.6K | 302,902 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2017-12-29 | 2018-01-03 | 7,589 | — | $0 | 41,852 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2017-10-12 | 2017-10-19 | 565,065 | $8.61 | $4.87M | 934,484 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2017-09-29 | 2017-10-03 | 7,482 | — | $0 | 34,263 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2017-09-27 | 2017-09-29 | 6,000 | — | $0 | 6,000 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2017-06-30 | 2017-07-05 | 6,810 | — | $0 | 26,781 | SEC↗ |
| OVAS OvaScience, Inc. | A Award deriv | 2017-06-21 | 2017-06-23 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2017-06-15 | 2017-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2017-03-31 | 2017-04-04 | 5,681 | — | $0 | 19,971 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2017-03-23 | 2017-03-27 | 12,000 | — | $0 | 12,000 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2016-12-30 | 2017-01-04 | 6,944 | $1.53 | $10.6K | 14,290 | SEC↗ |
| OVAS OvaScience, Inc. | G Gift | 2016-12-22 | 2017-01-04 | 154,519 | — | $0 | 7,346 | SEC↗ |
| OVAS OvaScience, Inc. | G Gift | 2016-12-22 | 2017-01-04 | 154,519 | — | $0 | 330,000 | SEC↗ |
| OVAS OvaScience, Inc. | G Gift | 2016-12-13 | 2017-01-04 | 645,842 | — | $0 | 161,865 | SEC↗ |
| OVAS OvaScience, Inc. | G Gift | 2016-12-13 | 2017-01-04 | 645,842 | — | $0 | 668,192 | SEC↗ |
| OVAS OvaScience, Inc. | G Gift | 2016-12-07 | 2017-01-04 | 200,000 | — | $0 | 0 | SEC↗ |
| OVAS OvaScience, Inc. | G Gift | 2016-12-07 | 2017-01-04 | 200,000 | — | $0 | 807,707 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award | 2016-11-21 | 2016-11-29 | 369,419 | — | $0 | 369,419 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2016-09-30 | 2016-10-04 | 1,483 | — | $0 | 607,707 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2016-06-09 | 2016-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OVAS OvaScience, Inc. | A Award deriv | 2016-06-02 | 2016-06-06 | 12,000 | — | $0 | 12,000 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-06-01 | 2016-06-03 | 425,000 | $7.00 | $2.98M | 962,056 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-05-18 | 2016-05-20 | 20,000 | $7.86 | $157.2K | 537,056 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-05-17 | 2016-05-18 | 20,000 | $7.56 | $151.2K | 517,056 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-05-13 | 2016-05-16 | 16,295 | $7.06 | $115.0K | 477,056 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-05-12 | 2016-05-16 | 5,600 | $7.13 | $39.9K | 460,761 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-05-12 | 2016-05-16 | 14,200 | $6.72 | $95.4K | 455,161 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-05-11 | 2016-05-13 | 20,000 | $7.64 | $152.8K | 440,961 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-05-10 | 2016-05-12 | 19,900 | $7.72 | $153.6K | 420,961 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2016-03-31 | 2016-04-04 | 1,119 | — | $0 | 604,185 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-24 | 2016-03-25 | 30,000 | $9.23 | $276.9K | 401,061 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-23 | 2016-03-25 | 8,100 | $10.18 | $82.5K | 371,061 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-23 | 2016-03-25 | 21,700 | $9.58 | $207.9K | 362,961 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-22 | 2016-03-23 | 29,800 | $10.53 | $313.8K | 341,261 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-21 | 2016-03-23 | 8,900 | $9.52 | $84.7K | 290,361 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-21 | 2016-03-23 | 21,100 | $10.71 | $226.0K | 311,461 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-18 | 2016-03-21 | 29,900 | $8.72 | $260.7K | 281,461 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-17 | 2016-03-21 | 29,800 | $7.79 | $232.1K | 251,561 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-16 | 2016-03-17 | 21,729 | $7.59 | $164.9K | 213,961 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-16 | 2016-03-17 | 7,800 | $8.13 | $63.4K | 221,761 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-15 | 2016-03-17 | 11,900 | $8.44 | $100.4K | 192,232 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-15 | 2016-03-17 | 17,600 | $7.80 | $137.3K | 180,332 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-14 | 2016-03-15 | 30,000 | $8.05 | $241.5K | 162,732 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2016-03-11 | 2016-03-15 | 132,732 | $7.50 | $995.5K | 132,732 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2015-12-31 | 2016-01-05 | 1,087 | — | $0 | 603,066 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-16 | 2015-12-17 | 20,000 | $19.76 | $395.2K | 286,975 | SEC↗ |
| OVAS OvaScience, Inc. | G Gift | 2015-10-19 | 2016-01-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| OVAS OvaScience, Inc. | G Gift | 2015-10-19 | 2016-01-05 | 200,000 | — | $0 | 601,979 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2015-09-30 | 2015-10-02 | 1,251 | — | $0 | 801,979 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2015-08-26 | 2015-08-28 | 82,405 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2015-08-26 | 2015-08-28 | 82,405 | — | $0 | 82,405 | SEC↗ |
| OVAS OvaScience, Inc. | G Gift | 2015-06-30 | 2017-01-04 | 175,481 | — | $0 | 175,481 | SEC↗ |
| OVAS OvaScience, Inc. | G Gift | 2015-06-30 | 2017-01-04 | 175,481 | — | $0 | 0 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2015-06-30 | 2016-07-05 | 2,039 | — | $0 | 606,224 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2015-06-30 | 2015-07-02 | 367 | $28.93 | $10.6K | 800,728 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2015-06-11 | 2015-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | M Exercise deriv | 2015-06-08 | 2015-06-10 | 7,000 | — | $0 | 13,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2015-06-08 | 2015-06-10 | 6,896 | $55.65 | $383.8K | 104 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | M Exercise | 2015-06-08 | 2015-06-10 | 7,000 | $10.85 | $76.0K | 7,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2015-06-08 | 2015-06-10 | 104 | $56.05 | $5.8K | 0 | SEC↗ |
| OVAS OvaScience, Inc. | A Award deriv | 2015-06-04 | 2015-06-08 | 12,000 | — | $0 | 12,000 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2015-05-16 | 2016-05-18 | 20,000 | $7.69 | $153.8K | 497,056 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2015-04-08 | 2015-04-09 | 2,500 | $29.97 | $74.9K | 22,350 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2015-03-31 | 2015-04-02 | 305 | $34.73 | $10.6K | 526,750 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2015-01-02 | 2015-01-02 | 12,000 | $51.00 | $612.0K | 12,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2014-10-16 | 2014-10-21 | 20,012 | — | $0 | 306,975 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2014-10-16 | 2014-10-21 | 82,405 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2014-10-16 | 2014-10-21 | 82,405 | — | $0 | 82,405 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2014-10-16 | 2014-10-21 | 20,012 | — | $0 | 82,405 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2014-07-07 | 2014-07-09 | 2,000 | $9.49 | $19.0K | 20,850 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2014-07-07 | 2014-07-16 | 1,000 | $9.49 | $9.5K | 19,850 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2014-06-30 | 2014-07-02 | 2,000 | $9.16 | $18.3K | 18,850 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2014-06-23 | 2014-06-25 | 2,000 | $8.81 | $17.6K | 16,850 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2014-06-16 | 2014-06-18 | 2,000 | $8.52 | $17.0K | 14,850 | SEC↗ |
| OVAS OvaScience, Inc. | A Award deriv | 2014-06-13 | 2014-06-17 | 6,500 | — | $0 | 6,500 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2014-06-10 | 2014-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2014-06-09 | 2014-06-11 | 2,000 | $7.59 | $15.2K | 12,850 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2014-06-02 | 2014-06-03 | 2,000 | $7.29 | $14.6K | 10,850 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2014-05-27 | 2014-05-29 | 2,000 | $7.50 | $15.0K | 8,850 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2014-05-20 | 2014-05-21 | 1,000 | $8.37 | $8.4K | 408,142 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2014-05-19 | 2014-05-21 | 2,000 | $7.33 | $14.7K | 6,850 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2014-03-07 | 2014-03-11 | 100,000 | $10.00 | $1.00M | 3,820,571 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-19 | 50,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-19 | 300,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-19 | 53,097 | — | $0 | 53,097 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-19 | 8,849 | — | $0 | 61,946 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2014-01-28 | 2014-01-31 | 10,000 | $27.05 | $270.5K | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2014-01-28 | 2014-01-31 | 10,000 | $27.05 | $270.5K | 10,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-11-11 | 2013-11-12 | 1,000 | $10.93 | $10.9K | 20,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-11-04 | 2013-11-04 | 1,000 | $10.51 | $10.5K | 19,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-10-28 | 2013-10-28 | 1,000 | $11.26 | $11.3K | 18,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-10-21 | 2013-10-21 | 1,000 | $12.57 | $12.6K | 17,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-10-14 | 2013-10-15 | 1,000 | $10.56 | $10.6K | 16,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-10-07 | 2013-10-07 | 1,000 | $11.53 | $11.5K | 15,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-09-30 | 2013-09-30 | 1,000 | $12.55 | $12.6K | 14,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-09-23 | 2013-09-23 | 1,000 | $13.17 | $13.2K | 13,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-09-16 | 2013-09-16 | 1,000 | $13.81 | $13.8K | 12,000 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2013-09-11 | 2013-09-12 | 4,850 | $10.54 | $51.1K | 4,850 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-09-09 | 2013-09-09 | 1,000 | $14.04 | $14.0K | 11,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-09-03 | 2013-09-03 | 1,000 | $14.07 | $14.1K | 10,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-08-26 | 2013-08-26 | 1,000 | $14.21 | $14.2K | 9,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-08-19 | 2013-08-19 | 1,000 | $13.45 | $13.4K | 8,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-08-12 | 2013-08-12 | 1,000 | $14.75 | $14.8K | 7,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-08-05 | 2013-08-05 | 1,000 | $15.25 | $15.3K | 6,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-07-29 | 2013-07-29 | 1,000 | $15.15 | $15.2K | 5,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-07-24 | 2013-07-24 | 1,000 | $16.39 | $16.4K | 4,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-07-15 | 2013-07-15 | 1,000 | $17.19 | $17.2K | 3,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-07-08 | 2013-07-10 | 1,000 | $14.69 | $14.7K | 2,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2013-07-01 | 2013-07-02 | 1,000 | $14.11 | $14.1K | 1,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | C Conversion deriv | 2013-06-25 | 2013-06-27 | 583,333 | — | $0 | 0 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | P Buy | 2013-06-25 | 2013-06-27 | 300,000 | $15.00 | $4.50M | 300,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | P Buy | 2013-06-25 | 2013-06-27 | 466,667 | $15.00 | $7.00M | 1,050,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | C Conversion | 2013-06-25 | 2013-06-27 | 583,333 | — | $0 | 583,333 | SEC↗ |
| OVAS OvaScience, Inc. | A Award deriv | 2013-06-07 | 2013-06-11 | 4,448 | — | $0 | 4,448 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2013-06-04 | 2013-06-06 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | P Buy deriv | 2013-05-15 | 2013-06-27 | 20,000 | $10.85 | $217.0K | 20,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | P Buy deriv | 2013-03-07 | 2013-06-27 | 583,333 | $12.00 | $7.00M | 583,333 | SEC↗ |
| OVAS OvaScience, Inc. | C Conversion deriv | 2012-08-13 | 2012-08-15 | 1,818,181 | — | $0 | 0 | SEC↗ |
| OVAS OvaScience, Inc. | C Conversion deriv | 2012-08-13 | 2012-08-15 | 3,000,000 | — | $0 | 0 | SEC↗ |
| OVAS OvaScience, Inc. | C Conversion | 2012-08-13 | 2012-08-15 | 1,482,946 | — | $0 | 1,658,427 | SEC↗ |
| OVAS OvaScience, Inc. | C Conversion | 2012-08-13 | 2012-08-15 | 1,818,181 | — | $0 | 3,476,608 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2012-03-06 | 2012-03-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion deriv | 2012-02-01 | 2012-02-03 | 444,444 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion deriv | 2012-02-01 | 2012-02-03 | 4,000,000 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion deriv | 2012-02-01 | 2012-02-03 | 3,500,000 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | A Award | 2012-02-01 | 2012-02-03 | 600,000 | $10.00 | $6.00M | 2,869,841 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion | 2012-02-01 | 2012-02-03 | 126,984 | — | $0 | 2,269,841 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion | 2012-02-01 | 2012-02-03 | 1,000,000 | — | $0 | 2,142,857 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion | 2012-02-01 | 2012-02-03 | 1,142,857 | — | $0 | 1,142,857 | SEC↗ |